Adagene Inc. has announced a partnership with ConjugateBio Inc. to provide a proprietary antibody for the development of innovative bispecific antibody-drug conjugates (ADCs).

“This is an important milestone in the development of ATI-052, our uniquely potent bispecific anti-TSLP/IL-4R antibody, for which we recently received IND clearance from the U.S. Food and Drug ...